Navigation and service

You are here:Risk Assessment Procedures

Hydroxyethyl starch (HES): Realisation of the EU Commission's implementing decision

Date 2015.12.16
Active substance hydroxyethyl starch

In a notice dated 30 September 2015, the Federal Institute for Drugs and Medical Devices (BfArM) has ruled suspension of the marketing authorisations of medicinal products from the company Serumwerk Bernburg AG containing HES until 30 September 2016.

To the risk assessment procedure (available in German only)